Cyclacel Pharmaceuticals Stock (NASDAQ: CYCC)
|Day Range1.31 - 1.37||52 Wk Range1.01 - 4.53||Open / Close1.34 / 1.32||Float / Outstanding12.2M / 12.5M|
|Vol / Avg.36.2K / 1.1M||Mkt Cap16.6M||P/E-||50d Avg. Price1.46|
|Div / Yield-||Payout Ratio-||Total Float12.2M||EPS-0.46|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cyclacel Pharmaceuticals (NASDAQ: CYCC) through any online brokerage.
The latest price target for Cyclacel Pharmaceuticals (NASDAQ: CYCC) was reported by Oppenheimer on Monday, July 18, 2022. The analyst firm set a price target for 17.00 expecting CYCC to rise to within 12 months (a possible 1187.88% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Cyclacel Pharmaceuticals (NASDAQ: CYCC) is $1.32 last updated September 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Cyclacel Pharmaceuticals.
Cyclacel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.